Week In Review: MassRoots’ Woes, GW Pharma’s Good News & Pro-Legalization Polls

Omar Sacirbey  | September 30, 2016

By Omar Sacirbey and John Schroyer

MassRoots lands in financial hot water, GW Pharmaceuticals takes a step closer to winning U.S. approval for its marijuana-based drug, and a political veteran urges caution heading into the elections.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Omar Sacirbey  |
September 30, 2016

New Colorado Edibles Rules: Major Cost for Producers, ‘Blip on the Radar’ for Others

John Schroyer  | September 29, 2016

By John Schroyer

New labeling rules that take effect Oct. 1 for marijuana edibles produced in Colorado have been a huge expense for many infused products manufacturers – and may cause headaches for retailers, too.

Edibles companies have spent upwards of six figures to retool manufacturing equipment, retrain employees and pay for new packaging. 

John Schroyer  |
September 29, 2016

Florida CBD Industry Inching Along, Eyeing November

Omar Sacirbey  | September 28, 2016

By Omar Sacirbey

Florida’s fledgling CBD market just launched but is proceeding at a snail’s pace, with the handful of licensed businesses hoping voters will approve a full-fledged medical marijuana program this fall.

For now, the current crop of CBD operators are hedging their bets on expanding their businesses ahead of the Nov. 8 election. 

Omar Sacirbey  |
September 28, 2016

Slow Launch Expected for Oregon’s Full Recreational Marijuana Market

John Schroyer  | September 27, 2016

By John Schroyer

Oregon dispensaries hoping to fully tap the state’s recreational marijuana market may have to wait longer than initially expected.

Many businesses had hoped to receive recreational marijuana licenses by now and start full sales in October, but it could take months for the lion’s share of them to get final approval. 

John Schroyer  |
September 27, 2016

Chart: New York Medical Marijuana Patient Counts Rising, But Still Have Long Way to Go

Eli McVey  | September 26, 2016

By Eli McVey

After an abysmal start, New York’s fledgling medical marijuana program is finally building momentum.

Since late January – shortly after the first dispensaries opened – the number of registered patients has grown by an average of 32% a month.

Eli McVey  |
September 26, 2016

Week in Review: Cannabis Election Map Set, Credit Unions Get Serious, Puerto Rico Fight

John Schroyer  | September 23, 2016

By John Schroyer and Omar Sacirbey

The November cannabis election map is essentially finalized, credit unions get serious about marijuana businesses, and a Denver attorney weighs in on the MJ software battle in Puerto Rico.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
September 23, 2016

Growing High-Quality Cannabis in a Greenhouse: Q&A with Matt Cohen

Omar Sacirbey  | September 22, 2016

By Omar Sacirbey

More marijuana growers are convinced you can grow a high-quality crop inside a greenhouse – one as good as that cultivated in an illuminated indoor grow.

Producing a good greenhouse crop requires a hefty investment in a high-tech facility. The capital outlay can be much more than growing outside or in a warehouse.

Omar Sacirbey  |
September 22, 2016